HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

TYK MEDICINES-B

22.600

-0.350-1.53%

Volume:182.00K

Turnover:4.16M

Market Cap:8.38B

PE:-18.05

High:23.300

Open:23.200

Low:22.550

Close:22.950

Loading ...

Overview Company News Filings

TYK Medicines' VP Steps Down

MT Newswires Live

BRIEF-TYK Medicines Says Jiang Mingyu Would Be Re-Designated To Non-Executive Director

Tyk Medicines Inc - Jiang Mingyu Would Be Re-Designated From Executive Director to Non-Executive Director

THOMSON REUTERS

TYK Medicines Included in Hang Seng Biotech Index

MT Newswires Live

BUZZ-China Literature drops on removal from Hang Seng Tech Index; Midea, ZTO up

TYK Medicines Inc. Joins Hang Seng Biotech Index

TYK Medicines Inc. Proposes Appointment of Dr. Zhu Xiangyang as Non-Executive Director

BRIEF-TYK Medicines To Invest RMB18.0 Million In Limited Partnership Fund

Tyk Medicines Inc - to Invest RMB18.0 Mln in Limited Partnership Fund Set up as per Joint Venture Agreement

THOMSON REUTERS

BRIEF-Tyk Medicines Posts FY Loss Attributable Rmb387 Million

Tyk Medicines Inc - FY Loss Attributable RMB387 Mln

THOMSON REUTERS

TYK Medicines, Inc's (HKG:2410) largest shareholders are private companies who were rewarded as market cap surged HK$3.3b last week

Simply Wall St.

TYK Medicines Concludes H-Share Full Circulation

MT Newswires Live

TYK Medicines Secures Hong Kong Exchange Listing Approval for Over 173.6 Million H Shares

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/02410/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02410","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02410\",,,,,undefined,":{"symbol":"02410","market":"HK","secType":"STK","nameCN":"TYK MEDICINES-B","latestPrice":22.6,"timestamp":1749189385143,"preClose":22.95,"halted":0,"volume":182000,"delay":0,"floatShares":366000000,"shares":371000000,"eps":-1.2523970510589213,"marketStatus":"Trading","change":-0.35,"latestTime":"06-06 13:56:35","open":23.2,"high":23.3,"low":22.55,"amount":4156475,"amplitude":0.03268,"askPrice":22.75,"askSize":1500,"bidPrice":22.6,"bidSize":2500,"shortable":3,"etf":0,"ttmEps":-1.2523970510589213,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1749197400000},"marketStatusCode":2,"adr":0,"listingDate":1724083200000,"exchange":"SEHK","adjPreClose":22.95,"openAndCloseTimeList":[[1749173400000,1749182400000],[1749186000000,1749196800000]],"volumeRatio":0.301074,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02410\",,,,,undefined,":{"symbol":"02410","floatShares":366000000,"roa":"-28.86%","roe":"--","lyrEps":-1.252395,"volumeRatio":0.301074,"shares":371000000,"dividePrice":0,"high":23.3,"amplitude":0.03268,"preClose":22.95,"low":22.55,"week52Low":12.86,"pbRate":"16.36","psRate":"71712.47","week52High":56.55,"institutionHeld":0,"latestPrice":22.6,"committee":0.25,"eps":-1.2523945497708797,"divideRate":0,"volume":182000,"delay":0,"ttmEps":-1.2523945497708797,"open":23.2,"prevYearClose":47.15,"prevWeekClose":20.1,"prevMonthClose":20.1,"prevQuarterClose":34.2,"fiveDayClose":20.1,"twentyDayClose":30.95,"sixtyDayClose":30.6},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02410\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2538677466","title":"TYK Medicines' VP Steps Down","url":"https://stock-news.laohu8.com/highlight/detail?id=2538677466","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538677466?lang=en_us&edition=fundamental","pubTime":"2025-05-27 20:14","pubTimestamp":1748348051,"startTime":"0","endTime":"0","summary":"Jiang Mingyu resigned as TYK Medicines'  vice president among other roles effective June 13 to devote more time to other business engagements, a Tuesday Hong Kong bourse filing said.Jiang will also be re-designated from an executive director to a non-executive director of the pharmaceutical company effective the same day.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MDCO","02410"],"gpt_icon":0},{"id":"2538454070","title":"BRIEF-TYK Medicines Says Jiang Mingyu Would Be Re-Designated To Non-Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2538454070","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538454070?lang=en_us&edition=fundamental","pubTime":"2025-05-27 17:46","pubTimestamp":1748339167,"startTime":"0","endTime":"0","summary":"BRIEF-TYK Medicines Says Jiang Mingyu Would Be Re-Designated To Non-Executive DirectorMay 27 (Reuters) - TYK Medicines Inc 2410.HK:JIANG MINGYU WOULD BE RE-DESIGNATED FROM EXECUTIVE DIRECTOR TO NON-EXECUTIVE DIRECTORFurther company coverage: 2410.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250527:nFWN3RY0WB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02410"],"gpt_icon":0},{"id":"2538459652","title":"Tyk Medicines Inc - Jiang Mingyu Would Be Re-Designated From Executive Director to Non-Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2538459652","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538459652?lang=en_us&edition=fundamental","pubTime":"2025-05-27 17:17","pubTimestamp":1748337456,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250527:nFWN3RY0WB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02410","BK1161"],"gpt_icon":0},{"id":"2536683922","title":"TYK Medicines Included in Hang Seng Biotech Index","url":"https://stock-news.laohu8.com/highlight/detail?id=2536683922","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536683922?lang=en_us&edition=fundamental","pubTime":"2025-05-19 18:44","pubTimestamp":1747651499,"startTime":"0","endTime":"0","summary":"TYK Medicines' (HKG:2410) H shares were selected for inclusion in the Hang Seng Biotech Index effective June 9, a Monday Hong Kong bourse filing said.The Hang Seng Biotech Index aims to reflect the overall performance of Hong Kong listed biotech companies.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","MDCO","02410"],"gpt_icon":0},{"id":"2536526374","title":"BUZZ-China Literature drops on removal from Hang Seng Tech Index; Midea, ZTO up","url":"https://stock-news.laohu8.com/highlight/detail?id=2536526374","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536526374?lang=en_us&edition=fundamental","pubTime":"2025-05-19 11:11","pubTimestamp":1747624270,"startTime":"0","endTime":"0","summary":"BUZZ-China Literature drops on removal from Hang Seng Tech Index; Midea, ZTO up** Shares of online literature and intellectual property incubation platform China Literature 0772.HK drop 8.3% to HK$24.20, their lowest since April 9** Stock on course for its biggest one-day pct decline since April 7; top pct loser on Hang Seng Tech Index .HSTECH, which falls 1%** Index compiler Hang Seng Indexes Co Ltd said on Friday China Literature will be removed from Hang Seng Tech Index .HSTECH, while BYD Co 1211.HK will be included in the index from June 9 ** Midea Group 0300.HK and ZTO Express 2057.HK will be added to the Hang Seng Index .HSI, increasing the number of constituents to 85 from 83** Shares of Midea and ZTO climb 1.8% and 3.7%, respectively** TYK Medicines 2410.HK and Kangji Medical 9997.HK will be added to Hang Seng Biotech Index .HSHKBIO, while Alphamab Oncology 9966.HK and RemeGen 9995.HK will be removed from the index** TYK and Kangji rise as much as 2.4% and 4.2%, respectively   ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"c713467fa5347bab03b18f7285ed8f71","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250519:nL1N3RR024:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0187","LU0049853897.USD","00772","02057","02410","LU0531971595.HKD","LU0588545730.USD","LU0572939691.SGD","HYDD.SI","000333","LU0231483743.USD","LU0918141887.USD","LU2399975544.HKD","LU2249611893.SGD","LU0955669360.SGD","SG9999001846.SGD","IE00B031HW06.USD","IE00BPRC5H50.USD","81211","LU1130305938.SGD","LU1997244956.HKD","002594","LU0819123356.HKD","LU0235996351.USD","00300","LU2506951792.HKD","BK1521","BK1522","HTCD.SI","LU0127658192.USD","LU0181495838.USD","LU1820825898.SGD","LU0502904849.HKD","09995","LU0611395673.USD","LU0348735423.USD","BYDDY","09997","LU0823397285.USD","EVS.SI","TCHmain","LU1770036033.HKD","LU2362541513.USD","SG9999013353.USD","LU0348783662.USD","BK1540","688331","09966"],"gpt_icon":1},{"id":"2536651083","title":"TYK Medicines Inc. Joins Hang Seng Biotech Index","url":"https://stock-news.laohu8.com/highlight/detail?id=2536651083","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536651083?lang=en_us&edition=fundamental","pubTime":"2025-05-19 08:01","pubTimestamp":1747612913,"startTime":"0","endTime":"0","summary":"TYK Medicines Inc. is set to be added to the Hang Seng Biotech Index, effective June 9, 2025. The inclusion reflects the capital market's recognition of the company's business performance and growth outlook.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TYK Medicines Inc. published the original content used to generate this news brief on May 19, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250519:nNDL560kcW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410","BK1161"],"gpt_icon":0},{"id":"2535520395","title":"TYK Medicines Inc. Proposes Appointment of Dr. Zhu Xiangyang as Non-Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2535520395","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535520395?lang=en_us&edition=fundamental","pubTime":"2025-05-16 19:05","pubTimestamp":1747393504,"startTime":"0","endTime":"0","summary":"TYK Medicines Inc. has announced a proposed appointment of Dr. Zhu Xiangyang as a non-executive director. The decision is pending approval from shareholders at the upcoming annual general meeting scheduled for June 26, 2025. Dr. Zhu, aged 64, brings over 20 years of experience in the biopharmaceutical industry and is currently serving as a consultant to the company.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TYK Medicines Inc. published the original content used to generate this news brief on May 16, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250516:nNDL1yRLm2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02410"],"gpt_icon":0},{"id":"2529953188","title":"BRIEF-TYK Medicines To Invest RMB18.0 Million In Limited Partnership Fund","url":"https://stock-news.laohu8.com/highlight/detail?id=2529953188","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529953188?lang=en_us&edition=fundamental","pubTime":"2025-04-24 23:18","pubTimestamp":1745507932,"startTime":"0","endTime":"0","summary":"BRIEF-TYK Medicines To Invest RMB18.0 Million In Limited Partnership FundApril 24 (Reuters) - TYK Medicines Inc 2410.HK:TO INVEST RMB18.0 MILLION IN LIMITED PARTNERSHIP FUND  SET UP  AS PER JOINT VENTURE AGREEMENTFurther company coverage: 2410.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250424:nFWN3R226F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410","BK1161"],"gpt_icon":0},{"id":"2529985502","title":"Tyk Medicines Inc -  to Invest RMB18.0 Mln in Limited Partnership Fund  Set up  as per Joint Venture Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2529985502","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529985502?lang=en_us&edition=fundamental","pubTime":"2025-04-24 19:58","pubTimestamp":1745495915,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250424:nFWN3R226F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02410"],"gpt_icon":0},{"id":"2522583013","title":"BRIEF-Tyk Medicines Posts FY Loss Attributable Rmb387 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2522583013","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522583013?lang=en_us&edition=fundamental","pubTime":"2025-03-27 23:27","pubTimestamp":1743089257,"startTime":"0","endTime":"0","summary":"BRIEF-Tyk Medicines Posts FY Loss Attributable Rmb387 MillionMarch 27 (Reuters) - TYK Medicines Inc 2410.HK:FY LOSS ATTRIBUTABLE RMB387 MILLIONFurther company coverage: 2410.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nFWN3QA0W1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02410"],"gpt_icon":0},{"id":"2522301183","title":"Tyk Medicines Inc - FY Loss Attributable RMB387 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2522301183","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522301183?lang=en_us&edition=fundamental","pubTime":"2025-03-27 21:52","pubTimestamp":1743083520,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nFWN3QA0W1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02410"],"gpt_icon":0},{"id":"2512462559","title":"TYK Medicines, Inc's (HKG:2410) largest shareholders are private companies who were rewarded as market cap surged HK$3.3b last week","url":"https://stock-news.laohu8.com/highlight/detail?id=2512462559","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512462559?lang=en_us&edition=fundamental","pubTime":"2025-02-20 07:42","pubTimestamp":1740008534,"startTime":"0","endTime":"0","summary":"Key Insights TYK Medicines' significant private companies ownership suggests that the key decisions are influenced by...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2410/tyk-medicines-shares/news/tyk-medicines-incs-hkg2410-largest-shareholders-are-private","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["02410","BK1161","MDCO"],"gpt_icon":0},{"id":"2512132033","title":"TYK Medicines Concludes H-Share Full Circulation","url":"https://stock-news.laohu8.com/highlight/detail?id=2512132033","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512132033?lang=en_us&edition=fundamental","pubTime":"2025-02-18 18:01","pubTimestamp":1739872897,"startTime":"0","endTime":"0","summary":"TYK Medicines  completed the conversion of 173,641,645 unlisted shares into Hong Kong shares on Tuesday, a same-day bourse filing said.The listing of the converted H shares will begin Wednesday, Feb. 19.The pharmaceutical products company applied for the H share full circulation in September 2024.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MDCO","BK1161","02410"],"gpt_icon":0},{"id":"2510411827","title":"TYK Medicines Secures Hong Kong Exchange Listing Approval for Over 173.6 Million H Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2510411827","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510411827?lang=en_us&edition=fundamental","pubTime":"2025-02-11 14:35","pubTimestamp":1739255748,"startTime":"0","endTime":"0","summary":"TYK Medicines  said the Listing Committee of the Stock Exchange of Hong Kong approved the listing of the company's 173,641,645 H shares on the exchange on Monday, a same-day bourse filing said.The said H shares are to be converted from the same number of unlisted shares held by 25 company shareholders. The exchange also granted permission to deal in the converted H shares to the company.The company had applied to the Exchange for the conversion and listing of the said shares on Sept. 13, 2024.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","02410","MDCO"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":14,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02410\",params:#limit:5,,,undefined,":[{"date":"2025-03-27","symbol":"02410","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743039000000,"name":null,"time":"","dateTimestamp":1743004800000,"actualEps":null},{"date":"2024-08-30","symbol":"02410","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724981400000,"name":null,"time":"","dateTimestamp":1724947200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02410\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02410\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02410\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02410","date":"2025-06-05","current":-19.130659,"percent":0.78866,"low":-45.171338,"twenty":-27.327907,"median":-23.977848,"eighty":-18.833408,"high":-10.104382,"avg":-24.288808,"sd":6.48572,"marketCap":8510682023},"quantilePoints":[{"date":"2024-08-23","current":-18.036629,"twenty":-16.647141,"median":-14.72623,"eighty":-12.008468,"marketCap":8010053668},{"date":"2024-08-30","current":-17.916348,"twenty":-18.108709,"median":-17.490261,"eighty":-14.277882,"marketCap":8010053668},{"date":"2024-09-06","current":-22.38992,"twenty":-20.387629,"median":-17.957821,"eighty":-15.985061,"marketCap":10531737231},{"date":"2024-09-13","current":-25.215246,"twenty":-24.52304,"median":-18.767123,"eighty":-16.911292,"marketCap":11829662594},{"date":"2024-09-20","current":-22.432724,"twenty":-24.518581,"median":-20.496807,"eighty":-17.208183,"marketCap":10587362603},{"date":"2024-09-27","current":-24.719835,"twenty":-24.497927,"median":-22.38992,"eighty":-17.671485,"marketCap":11736953639},{"date":"2024-10-04","current":-24.95032,"twenty":-24.87878,"median":-23.321155,"eighty":-17.932937,"marketCap":11792579012},{"date":"2024-10-10","current":-25.38933,"twenty":-24.941363,"median":-23.362473,"eighty":-17.973583,"marketCap":11922371548},{"date":"2024-10-18","current":-26.355956,"twenty":-25.311733,"median":-23.798709,"eighty":-18.108709,"marketCap":12311749157},{"date":"2024-10-25","current":-24.571342,"twenty":-25.374683,"median":-24.122054,"eighty":-18.545067,"marketCap":11477368567},{"date":"2024-11-01","current":-18.445843,"twenty":-25.311733,"median":-23.998666,"eighty":-18.584118,"marketCap":8621932768},{"date":"2024-11-08","current":-20.323115,"twenty":-25.278482,"median":-23.623818,"eighty":-17.973583,"marketCap":9456313359},{"date":"2024-11-15","current":-19.45318,"twenty":-25.171449,"median":-23.425489,"eighty":-18.108709,"marketCap":8955685004},{"date":"2024-11-22","current":-24.620137,"twenty":-24.988066,"median":-23.362473,"eighty":-18.406793,"marketCap":11329034239},{"date":"2024-11-29","current":-31.047836,"twenty":-25.311733,"median":-23.554037,"eighty":-18.584118,"marketCap":14277178993},{"date":"2024-12-06","current":-34.758675,"twenty":-25.786797,"median":-23.737743,"eighty":-19.168188,"marketCap":15945940174},{"date":"2024-12-13","current":-35.961329,"twenty":-26.0415,"median":-24.070769,"eighty":-19.324298,"marketCap":16465110319},{"date":"2024-12-20","current":-44.500897,"twenty":-30.298107,"median":-24.44033,"eighty":-19.494791,"marketCap":20284719244},{"date":"2024-12-27","current":-43.273475,"twenty":-31.455257,"median":-24.553474,"eighty":-19.619623,"marketCap":19709923726},{"date":"2025-01-03","current":-39.042242,"twenty":-33.760908,"median":-24.669986,"eighty":-19.709581,"marketCap":17800119264},{"date":"2025-01-10","current":-16.73771,"twenty":-34.083555,"median":-24.719835,"eighty":-19.709581,"marketCap":7602134269},{"date":"2025-01-17","current":-16.071561,"twenty":-33.760908,"median":-24.553474,"eighty":-18.860667,"marketCap":7305465614},{"date":"2025-01-24","current":-20.268382,"twenty":-32.413923,"median":-24.349989,"eighty":-19.230133,"marketCap":9270895450},{"date":"2025-01-28","current":-18.549699,"twenty":-31.591026,"median":-24.122054,"eighty":-18.549699,"marketCap":8529223814},{"date":"2025-02-07","current":-17.965815,"twenty":-31.472067,"median":-23.871541,"eighty":-18.275892,"marketCap":8214013368},{"date":"2025-02-14","current":-19.878813,"twenty":-31.451054,"median":-23.623818,"eighty":-18.275892,"marketCap":9066935750},{"date":"2025-02-21","current":-25.066745,"twenty":-31.047836,"median":-23.789321,"eighty":-18.32609,"marketCap":11495910358},{"date":"2025-02-28","current":-26.244856,"twenty":-30.411824,"median":-23.765234,"eighty":-18.39703,"marketCap":11996538712},{"date":"2025-03-07","current":-24.725844,"twenty":-30.135297,"median":-23.927628,"eighty":-18.445843,"marketCap":11347576030},{"date":"2025-03-14","current":-23.101371,"twenty":-29.84324,"median":-23.977848,"eighty":-18.549699,"marketCap":10605904394},{"date":"2025-03-21","current":-22.868028,"twenty":-28.789228,"median":-23.789321,"eighty":-18.691799,"marketCap":10494653649},{"date":"2025-03-28","current":-28.703724,"twenty":-28.703724,"median":-23.977848,"eighty":-19.110968,"marketCap":13146129748},{"date":"2025-04-03","current":-29.204856,"twenty":-29.744706,"median":-24.122054,"eighty":-19.131966,"marketCap":12070705875},{"date":"2025-04-11","current":-24.387234,"twenty":-29.307899,"median":-24.067881,"eighty":-19.145106,"marketCap":10012567086},{"date":"2025-04-17","current":-24.599189,"twenty":-28.955479,"median":-24.067881,"eighty":-19.224594,"marketCap":10123817831},{"date":"2025-04-25","current":-24.758022,"twenty":-28.755026,"median":-24.236021,"eighty":-19.282593,"marketCap":10197984995},{"date":"2025-05-02","current":-30.859428,"twenty":-28.772127,"median":-24.368612,"eighty":-19.308976,"marketCap":12738210348},{"date":"2025-05-09","current":-26.222368,"twenty":-28.789228,"median":-24.487968,"eighty":-19.376573,"marketCap":11477368567},{"date":"2025-05-16","current":-19.875071,"twenty":-28.703724,"median":-24.44033,"eighty":-19.45318,"marketCap":8770267095},{"date":"2025-05-23","current":-18.391406,"twenty":-28.460584,"median":-24.320388,"eighty":-19.147078,"marketCap":8139846205},{"date":"2025-05-30","current":-16.767615,"twenty":-28.328721,"median":-24.116277,"eighty":-18.777931,"marketCap":7453799941},{"date":"2025-06-05","current":-19.130659,"twenty":-27.327907,"median":-23.977848,"eighty":-18.833408,"marketCap":8510682023}],"updateTime":1749189384061}}}